GlassScriptPhysician profile
Bimal R Shah
NPI 1043319890
$7,361.76
in general payments reported to CMS, 2019-2025
33 companies · $581 in 2025
The $581 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,904 · 2020: $840 · 2021: $832 · 2022: $853 · 2023: $812 · 2024: $541 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,933.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,909.99 | 2019-2025 | Mitraclip |
| Janssen Pharmaceuticals, INC | $722.16 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $605.26 | 2019-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $594.41 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $583.73 | 2019-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $480.84 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $400.93 | 2019-2025 | Jardiance |
| Pfizer INC. | $397.31 | 2019-2025 | |
| Esperion Therapeutics, INC. | $293.04 | 2020-2024 | Nexletol |
| Boston Scientific Corporation | $268.28 | 2020-2025 | General - Stents, Watchman Flx, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.71 | 2019-2023 | Lifevest |
| Amgen INC. | $183.55 | 2019-2025 | Repatha, Repatha |
| Biotronik INC. | $95.88 | 2019-2020 | |
| Medicomp INC | $77.61 | 2023-2025 | Telepatch Cardiac Monitor |
| Alnylam Pharmaceuticals INC. | $46.78 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $44.96 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.44 | 2019-2025 | |
| Astellas Pharma US INC | $43.12 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $35.52 | 2023-2024 | Inpefa |
| Abiomed | $34.12 | 2025 | |
| Sanofi-Aventis U.S. LLC | $32.65 | 2019 | |
| Davol INC. | $30.92 | 2024 | Arista Ah Flexitip |
| Amarin Pharma, INC. | $26.65 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $25.96 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $25.68 | 2020-2021 | |
| Novo Nordisk INC | $24.91 | 2023 | |
| Medtronic, INC. | $21.35 | 2024 | Cobalt Dr Mri Surescan |
| Altathera Pharmaceuticals LLC | $19.49 | 2025 | Sotalol Hydrochloride |
| Glaxosmithkline, LLC. | $18.53 | 2025 | Shingrix, Arexvy |
| Daiichi Sankyo INC. | $17.93 | 2021 | |
| Coala Life INC | $16.05 | 2021 | |
| Cardiva Medical, INC. | $13.83 | 2022 | |
| Infobionic, INC | $12.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bimal Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.